- Trials with a EudraCT protocol (34)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
34 result(s) found for: Health care efficiency.
Displaying page 1 of 2.
EudraCT Number: 2020-000620-18 | Sponsor Protocol Number: RC20_0082 | Start Date*: 2021-02-19 | ||||||||||||||||
Sponsor Name:Nantes University Hospital | ||||||||||||||||||
Full Title: Human recombinant interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a double-blind, international phase 2, randomized, placebo-controlled trial - the... | ||||||||||||||||||
Medical condition: Patients hospitalized in intensive care units, under mechanical ventilation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001244-15 | Sponsor Protocol Number: D22-P006 | Start Date*: 2023-01-12 |
Sponsor Name:GHU Paris Psychiatrie et Neurosciences | ||
Full Title: Efficiency of a composite personalised care on functional outcome in early psychosis: A Prospective Randomised Controlled Trial - PsyCARE_Trial | ||
Medical condition: early psychosis | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001232-59 | Sponsor Protocol Number: AGO/2019/002 | Start Date*: 2020-01-29 | |||||||||||
Sponsor Name:Ghent University Hospital | |||||||||||||
Full Title: Safety and Efficacy of Patient Controlled Analgesia using the Sublingual Sufentanil Tablet System (SSTS) in a fast track rehabilitation program after Total Knee Arthroplasty. | |||||||||||||
Medical condition: Total Knee Arthroplasty | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-002177-34 | Sponsor Protocol Number: 10 150 02 | Start Date*: 2013-11-07 | |||||||||||
Sponsor Name:CHU de Toulouse | |||||||||||||
Full Title: Population pharmacokinetics of levofloxacin in intensive care patients with severe community-acquired pneumonia | |||||||||||||
Medical condition: community-acquired pneumonia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001966-87 | Sponsor Protocol Number: FCD-LOR-1402 | Start Date*: 2015-07-30 | |||||||||||
Sponsor Name:FERRER INTERNACIONAL, S.A. | |||||||||||||
Full Title: Double-blind, randomized, placebo-controlled cross-over dose finding study of two doses of lorediplon in adult patients with insomnia disorder | |||||||||||||
Medical condition: Insomnia disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) HR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002078-30 | Sponsor Protocol Number: REDNES06052013 | Start Date*: 2013-08-08 |
Sponsor Name:Onze-Lieve-Vrouw Ziekenhuis | ||
Full Title: Acceleromyography and diaphragm electromyographic activity during neostigmine or sugammadex enhanced recovery from moderate residual neuromuscular blockade after rocuronium 0.6 mg kg-1: a double bl... | ||
Medical condition: We will compare usual care (neostigmine) with sugammadex for reversal of a moderate rocuronium-induced neuromuscular blockade and assess the effect on diaphragmatic EMG activity of sugammadex versu... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003412-31 | Sponsor Protocol Number: BROVALE-2012(BC-POF2012) | Start Date*: 2012-10-01 | |||||||||||||||||||||
Sponsor Name:CUB - Hôpital Erasme | |||||||||||||||||||||||
Full Title: Efficiency and Safety of Ovarian Stimulation with Letrozole for fertility preservation in breast cancer patients. | |||||||||||||||||||||||
Medical condition: The aim of this trial is to offer a safe and efficient alternative protocol to preserve fertility by storing oocytes in breast cancer patients before chemotherapy. Letrozole, an inhibitor of aromat... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: BE (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003708-22 | Sponsor Protocol Number: E2015-PK-USI-BMR-COLISTIN | Start Date*: 2015-10-23 | |||||||||||
Sponsor Name:Hospital Erasme | |||||||||||||
Full Title: Colistin use in critically ill patients: pharmacokinetic population and pharmacodynamic studies, tolerance profil and risk of selection of resistance | |||||||||||||
Medical condition: Patients in intensive care unit suffering of infection by multi-drug resistance bacteria treated by colistin | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003245-29 | Sponsor Protocol Number: SA652013 | Start Date*: 2016-12-19 |
Sponsor Name:Amsterdam AMC, locatie AMC | ||
Full Title: Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after Roux-en-Y gastric bypass and Sleeve Gastrectomy | ||
Medical condition: Prevention of symptomatic gallstone disease | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-000805-26 | Sponsor Protocol Number: PSYKFORSK_MAT-MDD | Start Date*: 2021-11-19 |
Sponsor Name:Østfold Hospital Trust | ||
Full Title: An Open-Label, Phase 2, Feasibility Study of Manualized MDMA-Assisted Psychotherapy in Subjects with Major Depressive Disorder | ||
Medical condition: Major Depressive Disorder | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-005086-31 | Sponsor Protocol Number: 60258 | Start Date*: 2017-10-19 | |||||||||||
Sponsor Name:University Medical Center Utrecht (UMCU) | |||||||||||||
Full Title: Multicentre Randomised trial of Acute Stroke treatment in the Ambulance with a nitroglycerine Patch | |||||||||||||
Medical condition: Stroke | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004144-20 | Sponsor Protocol Number: CHUBX2014/24 | Start Date*: 2015-11-17 |
Sponsor Name:CHU de Bordeaux | ||
Full Title: Safety profile evaluation of TICagrelor Alone compared to a combination of lysine acetylsalicylate - Clopidogrel in the context of Transcatheter Aortic Valve Implantation (TAVI) | ||
Medical condition: Aortic valve stenosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004159-19 | Sponsor Protocol Number: 2018-00938 | Start Date*: Information not available in EudraCT |
Sponsor Name:University Hospital Basel | ||
Full Title: Use of Copeptin Measurement after Arginine Infusion for the Diagnosis of Diabetes Insipidus - the CARGOx Study | ||
Medical condition: Polyuria-polydipsia syndrome (PPS) is divided into the three main entities central (complete or partial) diabetes insipidus (DI), nephrogenic DI and primary polydipsia (PP). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-001514-26 | Sponsor Protocol Number: UIAPB-PRPULCERAS-2014 | Start Date*: 2015-01-15 | |||||||||||
Sponsor Name:Comarca Ezkerraldea-Enkarterri (OSAKIDETZA) | |||||||||||||
Full Title: Efficacy of Autologous Platelet-Rich Plasma in the treatment of vascular ulcers in Primary Care: Clinical trial phase III. | |||||||||||||
Medical condition: Patients with venous leg ulcers, between 40-100 years old, assigned to ten health centers in the county Ezkerraldea-Enkarterri Osakidetza Basque Health Service. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003893-29 | Sponsor Protocol Number: CASTLE | Start Date*: 2019-04-12 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Randomised factorial design controlled trial comparing carbamazepine, levetiracetam or active monitoring combined with or without sleep behaviour intervention in treatment naive children with rolan... | |||||||||||||
Medical condition: Rolandic Epilepsy | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002683-16 | Sponsor Protocol Number: TO-TAS-102-302 | Start Date*: 2016-01-20 | |||||||||||
Sponsor Name:Taiho Oncology, Inc | |||||||||||||
Full Title: RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY EVALUATING TAS-102 PLUS BEST SUPPORTIVE CARE (BSC) VERSUS PLACEBO PLUS BSC IN PATIENTS WITH METASTATIC GASTRIC CANCER REFRACTORY TO STANDARD TREATMENTS | |||||||||||||
Medical condition: Refractory metastatic gastric cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) BE (Completed) ES (Completed) IE (Completed) PT (Completed) CZ (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004286-25 | Sponsor Protocol Number: CX-401/FATT2 | Start Date*: 2008-12-04 | |||||||||||
Sponsor Name:CELLERIX S.A. | |||||||||||||
Full Title: Estudio fase III, multicéntrico, simple ciego, randomizado, controlado con placebo, para evaluar la eficacia y seguridad de células madre expandidas derivadas de tejido adiposo autólogo (eASCs) (CX... | |||||||||||||
Medical condition: Fístula perianal compleja en pacientes con enfermedad de Crohn. Complex perianal fistula in perianal Crohn´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) NL (Completed) AT (Prematurely Ended) DE (Prematurely Ended) BE (Completed) CZ (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000980-33 | Sponsor Protocol Number: 42847922ISM2005 | Start Date*: 2018-06-11 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Multicenter, Double-Blind, Randomized, Parallel-Group, Active- and Placebo-Controlled Polysomnography Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Subjects with Ins... | |||||||||||||
Medical condition: Insomnia Disorder | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) PL (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003986-25 | Sponsor Protocol Number: ADAMPA | Start Date*: 2017-05-05 | |||||||||||
Sponsor Name:Instituto de Investigación Sanitaria INCLIVA | |||||||||||||
Full Title: Impact of self-measurement of blood pressure and self-adjustment of antihypertensive medication in the control of hypertension and adherence to treatment. A pragmatic, randomized, controlled clinic... | |||||||||||||
Medical condition: Arterial hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000734-35 | Sponsor Protocol Number: BRAPP2 | Start Date*: 2014-08-06 | ||||||||||||||||
Sponsor Name:LYSARC | ||||||||||||||||||
Full Title: Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin’s lymphoma and FDG-PET positivity after 2 cycles of ABVD | ||||||||||||||||||
Medical condition: Patients aged from 18 to 70 years with supradiaphragmatic Ann Arbor clinical stage I or II classical Hodgkin lymphoma CD30+, FDG-PET positive score 4 & 5 according to Deauville criteria after 2 cou... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) BE (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
